The settlement comes after a complaint filed in Chicago’s federal court alleged Walgreens pharmacists filled illegal prescriptions for excessive quantities of opioids and prescriptions for a particularly dangerous combination of drugs.

Deerfield-based Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion. Shareholders could eventually receive up to another $3 per share under certain conditions.

The company said Tuesday that about 500 stores will close in the current fiscal year and should immediately support earnings and free cash flow. Walgreens didn’t say where the store closings would take place.

Walgreens will begin dispensing the medication within a week at some locations in several states, including Illinois.

CVS, Walgreens and Rite Aid are eliminating some locations as they face rising competition for these items from Amazon, big-box stores with pharmacies like Walmart, and Dollar General in rural areas.

The agency said the products are illegally marketed to treat conditions including conjunctivitis — known as pink eye — glaucoma and cataracts, and some of the warnings cited sterility issues with the products.

Last week, the location reopened with a dramatically pared back look. Why? Walgreens says it’s a digital-first experimental store to benefit customers. It’s not designed to deter theft, Walgreens says.

Several forces are pushing chains out of some city centers: a glut of stores, people working from home, online shopping, exorbitant rents, crime and public safety concerns, and difficulty hiring workers. To reinvent downtown retail, drastic changes may be required.

Walgreens says it’s peeling back spending on efforts to combat shoplifting. Machine company John Deere reaches a deal to let farmers repair their own equipment. And former Chicago Bear Brian Urlacher gets caught up in a hairy lawsuit.

Walgreens backs a deal to purchase a medical center company. The owners of a landmark hotel on Michigan Avenue are hunting for a buyer — again. And a new report finds Chicago’s affordable housing problem isn’t as bad as some other cities.

Walgreens extended its push into more comprehensive health care with its VillageMD unit acquiring another urgent and primary care chain, Summit Health-CityMD, in a deal worth close to $9 billion.

Two of the largest U.S. pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart is in discussions for a deal.

A major health care merger involving Deerfield-based Walgreens. Two Illinois nuclear plants that were once at risk of closing will now run for decades to come. And a new report finds that Illinois is among the top states where life sciences companies attract investment.

Two Chicago high-rises hit the market, leaving more than 700 downtown apartments up for sale. And a loan tied to a distressed hotel in River North sells at a steep discount.

Months of spot shortages at pharmacies and supermarkets have been exacerbated by the recall at Abbott, which was forced to shutter its largest U.S. formula manufacturing plant in February due to contamination concerns.

Deerfield-based Walgreens Boots Alliance is taking bids for its international drugstore chain, Boots. Boeing makes a $450 million investment in Wisk, an autonomous air-taxi start up. And Chicago’s Loop Capital announces its acquiring BMO Asset Management.